Systemic sclerosis: one year in review 2023.


Journal

Clinical and experimental rheumatology
ISSN: 0392-856X
Titre abrégé: Clin Exp Rheumatol
Pays: Italy
ID NLM: 8308521

Informations de publication

Date de publication:
Aug 2023
Historique:
received: 15 04 2023
accepted: 20 04 2023
medline: 4 8 2023
pubmed: 18 5 2023
entrez: 18 5 2023
Statut: ppublish

Résumé

Systemic sclerosis is a rare and chronic connective tissue disease resulting from an intricate pathogenesis and is expressed in very heterogeneous clinical manifestations. Every year many studies try to unravel and shed new insight into the pathogenesis, organ involvement and treatment of this complex and severe disease. We herein provide an overview of the most relevant studies published in the literature in 2022.

Identifiants

pubmed: 37199215
pii: 19876
doi: 10.55563/clinexprheumatol/ki76s5
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

1567-1574

Auteurs

Marco Di Battista (M)

Rheumatology Unit, Department of Clinical and Experimental Medicine, University of Pisa, and Department of Medical Biotechnologies, University of Siena, Italy.

Gemma Lepri (G)

Department of Experimental and Clinical Medicine, Division of Rheumatology, University of Florence, Italy.

Veronica Codullo (V)

Rheumatology Unit, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy.

Mattia Da Rio (M)

Rheumatology Unit, Department of Clinical and Experimental Medicine, University of Pisa, Italy.

Elisa Fiorentini (E)

Department of Experimental and Clinical Medicine, Division of Rheumatology, University of Florence, Italy.

Alessandra Della Rossa (A)

Rheumatology Unit, Department of Clinical and Experimental Medicine, University of Pisa, Italy. a.dellarossa@ao-pisa.toscana.it.

Serena Guiducci (S)

Department of Experimental and Clinical Medicine, Division of Rheumatology, University of Florence, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH